FLCNX
Price
$31.70
Change
+$0.05 (+0.16%)
Updated
Nov 8 closing price
RGEBX
Price
$78.53
Change
+$0.41 (+0.52%)
Updated
Nov 8 closing price
Ad is loading...

FLCNX vs RGEBX

Header iconFLCNX vs RGEBX Comparison
Open Charts FLCNX vs RGEBXBanner chart's image
Fidelity Contrafund K6
Price$31.70
Change+$0.05 (+0.16%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R2E
Price$78.53
Change+$0.41 (+0.52%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FLCNX vs RGEBX Comparison Chart
Loading...
VS
FLCNX vs. RGEBX commentary
Nov 11, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FLCNX is a Buy and RGEBX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 306B vs. FLCNX (34.6B). FLCNX pays higher dividends than RGEBX: FLCNX (0.45) vs RGEBX (0.16). FLCNX was incepted earlier than RGEBX: FLCNX (7 years) vs RGEBX (10 years). RGEBX is a more actively managed with annual turnover of: 31.00 vs. FLCNX (25.00). FLCNX has a lower initial minimum investment than RGEBX: FLCNX (0) vs RGEBX (250). FLCNX annual gain was more profitable for investors over the last year : 48.44 vs. RGEBX (35.75). FLCNX return over 5 years is better than : 135.23 vs. RGEBX (55.63).
FLCNXRGEBXFLCNX / RGEBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence7 years10 years-
Gain YTD37.66529.034130%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets34.6B306B11%
Annual Yield % from dividends0.450.16289%
Returns for 1 year48.4435.75135%
Returns for 3 years35.16-2.65-1,328%
Returns for 5 years135.2355.63243%
Returns for 10 yearsN/A68.53-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NDRA6.060.14
+2.36%
ENDRA Life Sciences Inc
WSR14.440.15
+1.05%
Whitestone REIT
CEIX128.020.36
+0.28%
CONSOL Energy
MCRB0.72N/A
N/A
Seres Therapeutics
APA21.77-0.16
-0.73%
APA Corp